109 related articles for article (PubMed ID: 32568934)
1. Guidance for Safe and Appropriate Use of Antibiotics in Hospice Using a Collaborative Decision Support Tool.
Sinert M; Stammet Schmidt MM; Lovell AG; Protus BM
J Hosp Palliat Nurs; 2020 Aug; 22(4):276-282. PubMed ID: 32568934
[TBL] [Abstract][Full Text] [Related]
2. Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warning.
Bratsman A; Mathias K; Laubscher R; Grigoryan L; Rose S
Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):701-707. PubMed ID: 32390266
[TBL] [Abstract][Full Text] [Related]
3. Macrolide and fluoroquinolone mediated cardiac arrhythmias: clinical considerations and comprehensive review.
Cornett E; Novitch MB; Kaye AD; Pann CA; Bangalore HS; Allred G; Bral M; Jhita PK; Kaye AM
Postgrad Med; 2017 Sep; 129(7):715-724. PubMed ID: 28770640
[TBL] [Abstract][Full Text] [Related]
4. Lessons Learned in Antibiotic Stewardship: Fluoroquinolone Use in Pediatrics.
Hersh AL; Gerber JS; Hicks LA; Pavia AT
J Pediatric Infect Dis Soc; 2015 Mar; 4(1):57-9. PubMed ID: 26407358
[TBL] [Abstract][Full Text] [Related]
5. Clinical Intentions of Antibiotics Prescribed Upon Discharge to Hospice Care.
Servid SA; Noble BN; Fromme EK; Furuno JP
J Am Geriatr Soc; 2018 Mar; 66(3):565-569. PubMed ID: 29345756
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Antibiotic Initiation Tools in End-of-Life Care.
Clark MD; Halford Z; Herndon C; Middendorf E
Am J Hosp Palliat Care; 2022 Mar; 39(3):274-281. PubMed ID: 34169763
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of FDA Boxed Warning on Prescribing Patterns of Fluoroquinolones for Uncomplicated Urinary Tract Infections.
Cowart K; Worley M; Rouby NE; Sando K
Ann Pharmacother; 2019 Dec; 53(12):1192-1199. PubMed ID: 31319681
[No Abstract] [Full Text] [Related]
8. Impact of FDA black box warning on fluoroquinolone and alternative antibiotic use in southeastern US hospitals.
Yarrington ME; Anderson DJ; Dodds Ashley E; Jones T; Davis A; Johnson M; Lokhnygina Y; Sexton DJ; Moehring RW
Infect Control Hosp Epidemiol; 2019 Nov; 40(11):1297-1300. PubMed ID: 31474240
[TBL] [Abstract][Full Text] [Related]
9. In the Line of Fire: Should Urologists Stop Prescribing Fluoroquinolones as Default?
Bonkat G; Wagenlehner F
Eur Urol; 2019 Feb; 75(2):205-207. PubMed ID: 30471884
[TBL] [Abstract][Full Text] [Related]
10. Surveillance of life-long antibiotics: a review of antibiotic prescribing practices in an Australian Healthcare Network.
Lau JS; Kiss C; Roberts E; Horne K; Korman TM; Woolley I
Ann Clin Microbiol Antimicrob; 2017 Jan; 16(1):3. PubMed ID: 28100229
[TBL] [Abstract][Full Text] [Related]
11. Fluoroquinolone use for uncomplicated urinary tract infections in women: a retrospective cohort study.
Daneman N; Chateau D; Dahl M; Zhang J; Fisher A; Sketris IS; Quail J; Marra F; Ernst P; Bugden S;
Clin Microbiol Infect; 2020 May; 26(5):613-618. PubMed ID: 31655215
[TBL] [Abstract][Full Text] [Related]
12. Fluoroquinolone-Associated Tendinopathy: Does Levofloxacin Pose the Greatest Risk?
Bidell MR; Lodise TP
Pharmacotherapy; 2016 Jun; 36(6):679-93. PubMed ID: 27138564
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of provider-chosen antibiotic indications as a targeted antimicrobial stewardship intervention.
Timmons V; Townsend J; McKenzie R; Burdalski C; Adams-Sommer V
Am J Infect Control; 2018 Oct; 46(10):1174-1179. PubMed ID: 29861148
[TBL] [Abstract][Full Text] [Related]
14. Fluoroquinolone-Induced Seizure in a Patient Receiving End-of-Life Care: A Case Report.
Baez Gonzalez J; Clark MD; Bruera E
J Palliat Med; 2023 Nov; 26(11):1590-1592. PubMed ID: 37319353
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic Policies and Utilization in Oregon Hospice Programs.
Novak RL; Noble BN; Fromme EK; Tice MO; McGregor JC; Furuno JP
Am J Hosp Palliat Care; 2016 Sep; 33(8):777-81. PubMed ID: 26268730
[TBL] [Abstract][Full Text] [Related]
16. Association between urinary community-acquired fluoroquinolone-resistant Escherichia coli and neighbourhood antibiotic consumption: a population-based case-control study.
Low M; Neuberger A; Hooton TM; Green MS; Raz R; Balicer RD; Almog R
Lancet Infect Dis; 2019 Apr; 19(4):419-428. PubMed ID: 30846277
[TBL] [Abstract][Full Text] [Related]
17. Decision support during electronic prescription to stem antibiotic overuse for acute respiratory infections: a long-term, quasi-experimental study.
Gifford J; Vaeth E; Richards K; Siddiqui T; Gill C; Wilson L; DeLisle S
BMC Infect Dis; 2017 Jul; 17(1):528. PubMed ID: 28760143
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the trends and appropriateness of fluoroquinolone use in the outpatient treatment of acute uncomplicated cystitis at five family practice clinics.
Robinson TF; Barsoumian AE; Aden JK; Giancola SE
J Clin Pharm Ther; 2020 Jun; 45(3):513-519. PubMed ID: 31821580
[TBL] [Abstract][Full Text] [Related]
19. Pattern of antibiotic prescriptions for outpatients with acute respiratory tract infections in Japan, 2013-15: a retrospective observational study.
Teratani Y; Hagiya H; Koyama T; Adachi M; Ohshima A; Zamami Y; Tanaka HY; Tatebe Y; Tasaka K; Mikami N; Shinomiya K; Kitamura Y; Kano MR; Hinotsu S; Sendo T
Fam Pract; 2019 Jul; 36(4):402-409. PubMed ID: 30272148
[TBL] [Abstract][Full Text] [Related]
20. Adverse Events in Older Adults Taking Fluoroquinolones.
Leipold A; Grupa T; Swanoski M
Sr Care Pharm; 2020 Aug; 35(8):355-359. PubMed ID: 32718392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
